Precancerous Lesion of Colon

2

Review clinical trials related to Precancerous Lesion of Colon. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Suturing Through-the-scope System Used for Prophylactic Closure of Colonic Post-ESD Defects

The goal of this study is to perform a randomized trial to compare a new through-the-scope suturing system and conventional clips for closure of defect after ESD for 30-60 mm colonic polyps. More precisely, the hypothesis posits that the new through-the-scope suturing system can achieve higher complete closure rates in a shorter time in comparison to conventional clips.

Participants needed: 66
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Istituto Clinico HumanitasUpdated: May 2, 2025
Eligibility criteria

Patient suffering from 30-60 mm colonic polyps with indication of ESD [+2]

Failure of endoscopic resection [+4]

Status: Recruiting

Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection

The objective of this low-risk interventional study is to evaluate whether the PreveCol® test has sufficient efficiency to be considered as a second-line method for the detection of both colorectal cancer and advanced adenomas when used prospectively in the screening population with a previous positive FOBT result, which could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to be answered are: * Values of efficacy, efficiency, impact and safety of PreveCol. * Values of preferences of participants for screening methods. * Values of PREMs into screening programme. Participants will provide a blood sample prior to a screening colonoscopy, and complete two questionnaires. They will give their sample, information and clinical data to the investigator or health care personnel.

Participants needed: 4,538
Trial details
Age: 50-69Biological sex: AllType: InterventionalSponsor: ADVANCED MARKER DISCOVERY S.L.Updated: Feb 27, 2025Locations: 2
Eligibility criteria

Participants ages from 50 to 69 years (both included) at the time of informed co... [+3]

Participants who have developed any another type of cancer in the 5 years prior... [+7]